B cell activity in immune-mediated neuropathies: Cellular requirements and cytokine effects for synthesis of anti-GM1 antibodies

Tekijä Heidenreich, F., Ewerhart, R.
Julkaisussa J Neuroimmunol (1994)

Candida albicans and Candida stellatoidea, in contrast to other Candida species, bind iC3b and C3d but not C3b.

Tekijä Heidenreich, F, Dierich, M P
Julkaistu 1985

Correlation of serum IL-13 and IL-5 levels with clinical response to Glatiramer acetate in patients with multiple sclerosis

Tekijä WIESEMANN, E, KLATT, J, WENZEL, C, HEIDENREICH, F, WINDHAGEN, A
Julkaistu 2003

Unusual presentation of a primary spinal Burkitt's lymphoma

Tekijä Wilkening, A, Brack, M, Brandis, A, Heidenreich, F, Dengler, R, Weibenborn, K
Julkaistu 2001

Lymphadenopathy in patients with multiple sclerosis undergoing treatment with glatiramer acetate

Tekijä WINDHAGEN, A, MANIAK, S, MARCKMANN, S, WILKENING, A, LINDERT, R, HEIDENREICH, F, BLASCZYK, R
Julkaistu 2001

Unusual presentation of a primary spinal lymphoma

Tekijä Jellinger, K, Grisold, W, Wilkening, A, Brack, M, Heidenreich, F, Dengler, R, Wei{beta}enborn, K, Brandis, A
Julkaistu 2002

Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation

Tekijä Link, C. S., Eugster, A., Heidenreich, F., Rücker‐Braun, E., Schmiedgen, M., Oelschlägel, U., Kühn, D., Dietz, S., Fuchs, Y., Dahl, A., Domingues, A. M. J., Klesse, C., Schmitz, M., Ehninger, G., Bornhäuser, M., Schetelig, J., Bonifacio, E.
Julkaisussa Clin Exp Immunol (2016)

Blood group A epitopes do not facilitate entry of SARS‐CoV‐2

Tekijä Schetelig, J., Baldauf, H., Wendler, S., Heidenreich, F., Real, R., Kolditz, M., Rosner, A., Dalpke, A., de With, K., Lange, V., Markert, J., Barth, R., Bunzel, C., Endert, D., Hofmann, J. A., Sauter, J., Bernas, S. N, Schmidt, A. H
Julkaisussa J Intern Med (2021)